Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Timentin and beta-lactamases.

R Labia, A Morand, J Péduzzi

    The Journal of Antimicrobial Chemotherapy
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Clavulanic acid effectively inhibits many bacterial beta-lactamases, enhancing the activity of ticarcillin against resistant bacteria like Pseudomonas aeruginosa. This combination therapy overcomes common resistance mechanisms, improving treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ultrafast laser-written 3D nano-antenna for flux extraction and vertical focusing above near-infrared waveguides.

    Optics express·2026
    Same author

    Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2025
    Same author

    Differences and similarities between Monkeypox and Chickenpox in children during an outbreak.

    Travel medicine and infectious disease·2024
    Same author

    Development of a 3D ultrafast laser written near-infrared spectro-interferometer.

    Optics letters·2023
    Same author

    Waveguide scattering antennas made by direct laser writing in bulk glass for spectrometry applications in the short-wave IR.

    Applied optics·2022
    Same author

    Real-life requests for Bordetella polymerase chain reaction testing in children presenting to hospital.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2021
    Same journal

    Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

    The Journal of antimicrobial chemotherapy·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Pharmacology
    • Biochemistry

    Background:

    • Ticarcillin exhibits broad-spectrum activity, including against cephalosporinase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
    • Bacterial resistance to ticarcillin is often mediated by beta-lactamases, particularly plasmid-mediated penicillinases.
    • Clavulanic acid, a beta-lactamase inhibitor, possesses limited intrinsic antibacterial activity but is crucial for overcoming enzymatic resistance.

    Purpose of the Study:

    • To investigate the inhibitory effects of clavulanic acid on a diverse range of bacterial beta-lactamases.
    • To correlate the inhibitory profile of clavulanic acid with the antibacterial efficacy of ticarcillin/clavulanic acid (Timentin).

    Main Methods:

    • Assay of clavulanic acid's inhibitory activity against various beta-lactamases, including penicillinases and cephalosporinases from different bacterial species.

    Related Experiment Videos

  • Evaluation of inhibition potency against plasmid-mediated (e.g., TEM, OXA) and chromosomally-mediated (e.g., Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli AmpC) beta-lactamases.
  • Assessment of clavulanic acid's cephalosporinase-inducing properties.

    • Main Results:

    • Clavulanic acid strongly inhibited beta-lactamases from Staphylococcus aureus, TEM-type, Klebsiella pneumoniae, and Proteus vulgaris.
    • Inhibition was less potent or poor against OXA-type penicillinases and chromosomally-mediated cephalosporinases like Escherichia coli AmpC.
    • Clavulanic acid demonstrated cephalosporinase-inducing properties.

    Conclusions:

    • Clavulanic acid effectively neutralizes a significant spectrum of bacterial beta-lactamases, thereby potentiating the activity of ticarcillin.
    • The observed inhibitory profile of clavulanic acid aligns with the established bacteriological effectiveness of the combination drug Timentin.
    • Understanding beta-lactamase inhibition is key to optimizing antibiotic therapy against resistant bacterial infections.